United Therapeutics (UTHR) Return on Sales [ROS] (2009 - 2026)
United Therapeutics (UTHR) reported Return on Sales [ROS] of 42.23% for Q2 2026, down 3.41 percentage points from 45.64% a year earlier but up 0.54 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, United Therapeutics' Return on Sales [ROS] came in at 44.44%, down 2.61 percentage points year-over-year; for FY2025, it came in at 46.89%, down 0.96 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of +6.88 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at 47.86% in FY2024 (-3.05 pp), 50.91% in FY2023 (+0.31 pp), 50.60% in FY2022 (+17.62 pp) and 32.98% in FY2021 (-7.04 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of 35.73% in Q4 2022 and a high of 62.35% in Q1 2022.
- Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of -1.96 percentage points over the last eight quarters.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2022 (a gain of 79.44 percentage points); the low point was Q3 2024 (a drop of 7.85 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 41.69% (Q1 2026), 45.14% (Q4 2025) and 48.59% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | United Therapeutics | 24.95 Bn | 15.14 Bn | 733.40 Mn | 36.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.97% |
| Jun 30, 2026 | 42.23% |
| Mar 31, 2026 | 41.69% |
| Dec 31, 2025 | 45.14% |
| Sep 30, 2025 | 48.59% |
| Jun 30, 2025 | 45.64% |
| Mar 31, 2025 | 48.19% |
| Dec 31, 2024 | 48.61% |
| Sep 30, 2024 | 45.81% |
| Jun 30, 2024 | 44.75% |
| Mar 31, 2024 | 52.57% |
| Dec 31, 2023 | 42.31% |
| Sep 30, 2023 | 53.66% |
| Jun 30, 2023 | 52.54% |
| Mar 31, 2023 | 56.11% |
| Dec 31, 2022 | 35.73% |
| Sep 30, 2022 | 60.91% |
| Jun 30, 2022 | 43.22% |
| Mar 31, 2022 | 62.35% |
| Dec 31, 2021 | 40.90% |
API Access
United Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();